{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:52:42Z","timestamp":1781488362595,"version":"3.54.1"},"reference-count":31,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Normogonadotropic azoospermia (NOAN) represents a diagnostic and therapeutic challenge in male infertility, affecting men with normal gonadotropin levels but absent sperm in the ejaculate. Emerging evidence has identified 17-hydroxyprogesterone (17OHP) as a potential biomarker for detecting reduced intratesticular testosterone (ITT) levels, and the presence of round spermatids in ejaculate as an indicator of residual spermatogenic activity. This report synthesizes current evidence on a proposed hypothesis-generating diagnostic framework that utilizes these markers to guide hormonal treatment strategies. Specifically, patients with elevated 17OHP levels (&gt;1.18 ng\/mL) and detectable round spermatids may benefit from combined human chorionic gonadotropin (hCG) and follicle-stimulating hormone (FSH) therapy at doses lower than those used for hypogonadotropic hypogonadism. However, this cutoff has not been prospectively validated in NOAN-specific cohorts, and the evidence supporting this approach remains preliminary, derived from small heterogeneous cohorts. Alternative therapeutic strategies, including FSH monotherapy and non-hormonal pharmacological treatments, are also discussed. This framework requires rigorous prospective validation before clinical implementation.<\/jats:p>","DOI":"10.3390\/diagnostics16121830","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:44:58Z","timestamp":1781484298000},"page":"1830","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel Diagnostic Algorithm for Azoospermia: The Role of 17-Hydroxyprogesterone and Round Spermatids in Normogonadotropic Azoospermia"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7113-2372","authenticated-orcid":false,"given":"Sandro","family":"La Vignera","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5217-9343","authenticated-orcid":false,"given":"Rosita A.","family":"Condorelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.12703\/r\/10-7","article-title":"Non-obstructive azoospermia: Current and future perspectives","volume":"10","author":"Tharakan","year":"2021","journal-title":"Fac. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/2090598X.2021.1956233","article-title":"Medical management of non-obstructive azoospermia: A systematic review","volume":"19","author":"Alkandari","year":"2021","journal-title":"Arab. J. Urol."},{"key":"ref_3","first-page":"1221","article-title":"ITT and spermatogenesis","volume":"76","author":"Schaison","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","unstructured":"La Vignera, S., and Condorelli, R.A. (2024). Novel diagnostic algorithm for azoospermia. Preliminary data. Internal Report, University of Catania."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4103\/1008-682X.148719","article-title":"Clinical management of infertile men with nonobstructive azoospermia","volume":"17","author":"Esteves","year":"2015","journal-title":"Asian J. Androl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/humrep\/deg348","article-title":"Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions","volume":"18","author":"Hopps","year":"2003","journal-title":"Hum. Reprod."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/aja.2012.141","article-title":"Microdissection testicular sperm extraction: An update","volume":"15","author":"Dabaja","year":"2013","journal-title":"Asian J. Androl."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/humrep\/der404","article-title":"Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction","volume":"27","author":"Shiraishi","year":"2012","journal-title":"Hum. Reprod."},{"key":"ref_9","first-page":"4462","article-title":"Human FSH stimulatory effect on spermatogenesis","volume":"151","author":"Weinbauer","year":"2010","journal-title":"Endocrinology"},{"key":"ref_10","first-page":"e123","article-title":"Efficacy of gonadotropin therapy to induce spermatogenesis in men with pathologic gonadotropin deficiency","volume":"110","author":"Gialouris","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","first-page":"312","article-title":"Predictors of micro-TESE outcomes","volume":"12","author":"Enafaa","year":"2016","journal-title":"Nephrol. Ther."},{"key":"ref_12","first-page":"429","article-title":"17-\u03b1-OH-Progesterone to testosterone plasma ratios and their modification after HCG in normal men and in patients with idiopathic infertility","volume":"20","author":"Abbaticchio","year":"1988","journal-title":"Andrologia"},{"key":"ref_13","first-page":"E620","article-title":"Evaluation of serum 17-hydroxyprogesterone as predictor of semen parameter improvement","volume":"14","author":"Lima","year":"2020","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_14","first-page":"23","article-title":"Testicular echotexture as predictor of NOA outcomes","volume":"14","author":"Fu","year":"2024","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_15","first-page":"2691","article-title":"Testosterone and dexamethasone in congenital adrenal hyperplasia","volume":"95","author":"Collet","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/humrep\/16.7.1427","article-title":"May\u2013Gr\u00fcnwald\u2013Giemsa stain for detection of spermatogenic cells","volume":"16","author":"Amer","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_17","first-page":"113","article-title":"NOA: Prevalence and hypospermatogenesis","volume":"4","author":"Achermann","year":"2023","journal-title":"F&S Rev."},{"key":"ref_18","first-page":"93","article-title":"hCG+FSH pre-microTESE in NOA","volume":"20","author":"Peng","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_19","first-page":"42","article-title":"Sexual and hormonal profiles of infertile subjects with non-obstructive azoospermia","volume":"10","author":"Behzad","year":"2009","journal-title":"J. Reprod. Infertil."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1507\/endocrj.EJ17-0001","article-title":"Gonadotropin actions on spermatogenesis and hormonal therapies for spermatogenic disorders","volume":"64","author":"Shiraishi","year":"2017","journal-title":"Endocr. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1210\/jcem-61-4-746","article-title":"Male hypogonadotropic hypogonadism: Factors influencing response to hCG and hMG","volume":"61","author":"Ley","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","first-page":"980","article-title":"Subcutaneous self-administration of highly purified FSH and hCG for male hypogonadotrophic hypogonadism","volume":"12","author":"Calderon","year":"1997","journal-title":"Hum. Reprod."},{"key":"ref_23","first-page":"512","article-title":"Recombinant gonadotropin therapy in nonobstructive azoospermic patients\u2014Proof of concept","volume":"48","author":"Hussein","year":"2022","journal-title":"Int. Braz. J. Urol."},{"key":"ref_24","first-page":"e14251","article-title":"HCG therapy in azoospermic men with lower\/borderline testosterone","volume":"53","author":"Andrabi","year":"2021","journal-title":"Andrologia"},{"key":"ref_25","first-page":"764","article-title":"Germ cells in semen of azoospermic patients","volume":"67","author":"Yeung","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e14596","DOI":"10.1111\/and.14596","article-title":"FSH can improve semen parameters in idiopathic oligoasthenoteratozoospermia: A systematic review and meta-analysis","volume":"54","author":"Zhang","year":"2022","journal-title":"Andrologia"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Al Wattar, B.H., Rimmer, M.P., Teh, J.J., Mackenzie, S.C., Ammar, O.F., Croucher, C., Anastasiadis, E., Gordon, P., Pacey, A., and McEleny, K. (2024). Pharmacological non-hormonal treatment options for male infertility. BMC Urol., 24.","DOI":"10.1186\/s12894-024-01545-1"},{"key":"ref_28","unstructured":"Shapiro, E., and Sherins, R.J. (2014). Endocrine Stimulatory Therapy for Testis Sperm Extraction, Academic Press. [4th ed.]."},{"key":"ref_29","first-page":"10","article-title":"Male infertility due to spermatogenic failure","volume":"12","author":"Esteves","year":"2015","journal-title":"Anim. Reprod."},{"key":"ref_30","first-page":"74","article-title":"Highly purified urofollitropin in idiopathic azoospermia","volume":"85","author":"Cocci","year":"2018","journal-title":"Riv. Urol."},{"key":"ref_31","first-page":"365","article-title":"Induction of spermatogenesis by rhFSH in azoospermia","volume":"61","author":"Kobori","year":"2015","journal-title":"Syst. Biol. Reprod. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/12\/1830\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:07:45Z","timestamp":1781485665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/12\/1830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["diagnostics16121830"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16121830","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}